Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Depreciation & Amortization (CF) (2016 - 2025)

Palisade Bio (PALI) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $1000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) changed 0.0% to $1000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $3000.0, a 0.0% change, with the full-year FY2024 number at $3000.0, down 25.0% from a year prior.
  • Depreciation & Amortization (CF) was $1000.0 for Q3 2025 at Palisade Bio, roughly flat from $1000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2000.0 in Q4 2022 to a low of $1000.0 in Q1 2021.
  • A 5-year average of $1166.7 and a median of $1000.0 in 2021 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): crashed 96.56% in 2021, then changed 0.0% in 2022.
  • Palisade Bio's Depreciation & Amortization (CF) stood at $1000.0 in 2021, then surged by 100.0% to $2000.0 in 2022, then plummeted by 50.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Depreciation & Amortization (CF) are $1000.0 (Q3 2025), $1000.0 (Q2 2025), and $1000.0 (Q1 2025).